The Antidepressant Dilemma (New York Times Magazine, free reg. req’d)
On June 30, 1997, the Millers took Matt to see Dr. Douglas Geenens, a child psychiatrist referred to them by Matt’s primary-care physician. In addition to the doctor and the Millers, both Mark and Cheryl remember there being two other people in the room, who Dr. Geenens explained were his trainees. Matt sat silently for almost the entire 50-minute session. Cheryl did most of the talking, sketching out Matt’s emotional deterioration since the start of the calendar year.
Matt’s next appointment with Dr. Geenens was scheduled for July 21, a Monday. Mark and Cheryl recalled the details for me: Matt took a 30-minute test for attention deficit disorder and spent 15 minutes filling out a Children’s Depression Inventory form, a standard tool for measuring depression in kids. At the end of the session, Dr. Geenens suggested that Matt try Zoloft. He gave the Millers three sample bottles with seven 50-milligram tablets in each and told them to make sure that Matt took one a day. The Millers had never heard of it. ”The only thing I was aware of was Prozac,” Cheryl told me. ”I asked him why are you prescribing Zoloft?” Dr. Geenens answered that Zoloft was newer and more refined than Prozac. Cheryl asked if there were any possible side effects. Dr. Geenens said they should be on the lookout for stomachaches or insomnia. The doctor had no appointments available until the middle of August, but he wanted the Millers to call in a week and let him know how Matt was doing.
This longish article in the NY Times Magazine section last week is worth the read… About the tragedy that surrounds a family who’s teenage son committed suicide while on an antidepressant medication.
(No Ratings Yet)
Loading ...You can skip to the end and leave a response. Pinging is currently not allowed.
Join the Conversation! Post a Comment:
Last reviewed: By John M. Grohol, Psy.D. on 24 Nov 2004
